CAT No: AAD-475
CAS No:56523-61-6
Synonyms/Alias:gamma-Glutamylornithine;Gamma glutamyl ornithine;56523-61-6;(4S)-4-amino-5-[[(1S)-4-amino-1-carboxybutyl]amino]-5-oxopentanoic acid;L-Ornithine, N2-L-gamma-glutamyl-, stereoisomer;gamma-Glu-orn;(2S)-5-AMINO-2-[(2S)-2-AMINO-4-CARBOXYBUTANAMIDO]PENTANOIC ACID;glutamylornithine;(2S)-5-amino-2-((2S)-2-amino-4-carboxybutanamido)pentanoic acid;(4S)-4-Amino-4-(((1S)-4-amino-1-carboxybutyl)-C-hydroxycarbonimidoyl)butanoate;(4S)-4-Amino-4-{[(1S)-4-amino-1-carboxybutyl]-C-hydroxycarbonimidoyl}butanoate;g-Glutamylornithine;g Glutamyl ornithine;L-gamma-glutamyl-L-ornithine;DTXSID80971966;CHEBI:173862;DB-289982;NS00121251;N~2~-(2-Amino-4-carboxy-1-hydroxybutylidene)ornithine;(4S)-4-amino-4-[[(1s)-4-amino-1-carboxy-butyl ]carbamoyl ]butanoic acid;(S)-4-amino-5-(((S)-4-amino-1-carboxybutyl)amino)-5-oxopentanoic acid;
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More